Quantum BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.91	6	2.76	16.98	35.26
Short-Term Investments	0.46	1.2	0.76	-	0.16
Cash & Short-Term Investments	2.36	7.2	3.51	16.98	35.42
Cash Growth	-67.15%	104.89%	-79.31%	-52.06%	102.10%
Accounts Receivable	-	3.43	7.19	0.02	-
Other Receivables	0.23	0.37	0.23	0.37	0.5
Receivables	0.23	3.81	7.42	0.4	0.5
Inventory	0.05	0.12	-	-	-
Prepaid Expenses	0.02	0.04	0.12	0.16	0.76
Other Current Assets	3.82	0.89	0.03	0.31	9.25
Total Current Assets	6.48	12.05	11.09	17.85	45.93
Property, Plant & Equipment	0.17	0.13	0.12	0.26	0.17
Long-Term Investments	-	0	0.01	0.83	0.66
Other Intangible Assets	4.51	4.93	5.36	12.04	16.2
Long-Term Accounts Receivable	-	-	0.91	7.43	-
Total Assets	11.16	17.12	17.47	38.41	62.96
Accounts Payable	4.18	3.25	3.24	2.76	3
Accrued Expenses	-	1.11	0.95	4.35	4.46
Short-Term Debt	1.3	0.62	0.3	0.3	0.3
Current Portion of Long-Term Debt	0.47	0.15	-	-	-
Current Portion of Leases	0.1	0.05	0.04	0.18	0.12
Current Unearned Revenue	-	1	-	-	-
Other Current Liabilities	-	0.49	0.03	0.24	0.83
Total Current Liabilities	6.06	6.68	4.57	7.83	8.7
Long-Term Leases	-	-	-	0.04	0.13
Total Liabilities	6.06	6.68	4.57	7.87	8.83
Common Stock	169.7	150.47	137.78	143.41	152.32
Additional Paid-In Capital	35.41	31.07	30.23	28.5	22.58
Retained Earnings	-198.29	-172.11	-157.91	-144.16	-126.15
Comprehensive Income & Other	0.1	2.05	3.14	2.8	5.38
Total Common Equity	6.92	11.48	13.24	30.54	54.13
Minority Interest	-1.82	-1.04	-0.33	-	-
Shareholders' Equity	5.1	10.44	12.91	30.54	54.13
Total Liabilities & Equity	11.16	17.12	17.47	38.41	62.96
Total Debt	1.88	0.82	0.34	0.52	0.56
Net Cash (Debt)	0.49	6.37	3.17	16.46	34.86
Net Cash Growth	-92.34%	100.80%	-80.72%	-52.77%	104.90%
Net Cash Per Share	0.15	5.61	5.21	27.63	64.84
Filing Date Shares Outstanding	3.83	2.71	0.62	0.63	0.59
Total Common Shares Outstanding	3.83	2.3	0.61	0.59	0.62
Working Capital	0.42	5.37	6.52	10.02	37.23
Book Value Per Share	1.81	4.99	21.85	51.56	86.98
Tangible Book Value	2.41	6.55	7.88	18.5	37.93
Tangible Book Value Per Share	0.63	2.85	13.01	31.23	60.95

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q